ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Interventional Pain Medicine

Top Interventional Pain Medicine Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
YOGESH MALLA M.D.

Interventional Pain Medicine

14,568

$534K

1251
280 are 65+

40%
patients receiving schedule two controlled substances

Avg: 46%

61%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 14%

$37
Average prescription price

Avg: $60

LAXMAIAH MANCHIKANTI M.D.

Interventional Pain Medicine

11,556

$439K

1193
253 are 65+

38%
patients receiving schedule two controlled substances

Avg: 46%

56%
patients receiving schedule three controlled substances

Avg: 41%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 14%

$38
Average prescription price

Avg: $60

KATHERINE BALLARD M.D.

Interventional Pain Medicine

10,763

$711K

1258
254 are 65+

72%
patients receiving schedule two controlled substances

Avg: 46%

35%
patients receiving schedule three controlled substances

Avg: 41%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 14%

$66
Average prescription price

Avg: $60

SAI GUTTI MD

Interventional Pain Medicine

9,440

$276K

746
163 are 65+

4%
patients receiving schedule two controlled substances

Avg: 46%

76%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 14%

$29
Average prescription price

Avg: $60

JOHN KELLY MD

Interventional Pain Medicine

8,557

$650K

819
374 are 65+

67%
patients receiving schedule two controlled substances

Avg: 46%

25%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 14%

$76
Average prescription price

Avg: $60

JEFFREY BERG M.D.

Interventional Pain Medicine

7,899

$415K

649
328 are 65+

33%
patients receiving schedule two controlled substances

Avg: 46%

60%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 14%

$53
Average prescription price

Avg: $60

BRENDON COUGHTRY M.D.

Interventional Pain Medicine

7,614

$373K

438
124 are 65+

33%
patients receiving schedule two controlled substances

Avg: 46%

67%
patients receiving schedule three controlled substances

Avg: 41%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 14%

$49
Average prescription price

Avg: $60

SUK KIM M.D.

Interventional Pain Medicine

7,193

$436K

589
297 are 65+

44%
patients receiving schedule two controlled substances

Avg: 46%

51%
patients receiving schedule three controlled substances

Avg: 41%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 14%

$61
Average prescription price

Avg: $60

CHRISTOPHER NELSON M.D.

Interventional Pain Medicine

7,044

$583K

1055
245 are 65+

66%
patients receiving schedule two controlled substances

Avg: 46%

42%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

9%
prescriptions for brand name drugs

Avg: 14%

$83
Average prescription price

Avg: $60

GARY REASOR M.D.

Interventional Pain Medicine

6,474

$546K

497
213 are 65+

64%
patients receiving schedule two controlled substances

Avg: 46%

41%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 14%

$84
Average prescription price

Avg: $60

LAUREN LARSON M.D.

Interventional Pain Medicine

6,352

$443K

749
163 are 65+

74%
patients receiving schedule two controlled substances

Avg: 46%

33%
patients receiving schedule three controlled substances

Avg: 41%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 14%

$70
Average prescription price

Avg: $60

MICHAEL FLETCHER MD

Interventional Pain Medicine

5,933

$509K

862
183 are 65+

74%
patients receiving schedule two controlled substances

Avg: 46%

28%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 14%

$86
Average prescription price

Avg: $60

RAMARAO PASUPULETI MD

Interventional Pain Medicine

4,938

$281K

531
177 are 65+

46%
patients receiving schedule two controlled substances

Avg: 46%

56%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 14%

$57
Average prescription price

Avg: $60

JUSTIN KRUER M.D.

Interventional Pain Medicine

4,883

$406K

669
325 are 65+

65%
patients receiving schedule two controlled substances

Avg: 46%

28%
patients receiving schedule three controlled substances

Avg: 41%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 14%

$83
Average prescription price

Avg: $60

HAROLD RUTLEDGE MD

Interventional Pain Medicine

3,606

$281K

223
72 are 65+

55%
patients receiving schedule two controlled substances

Avg: 46%

47%
patients receiving schedule three controlled substances

Avg: 41%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 14%

$78
Average prescription price

Avg: $60

MICHAEL WALLS M.D.

Interventional Pain Medicine

3,312

$238K

354
165 are 65+

67%
patients receiving schedule two controlled substances

Avg: 46%

31%
patients receiving schedule three controlled substances

Avg: 41%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 14%

$72
Average prescription price

Avg: $60

DAVID BOSOMWORTH M.D.

Interventional Pain Medicine

3,246

$194K

251
97 are 65+

55%
patients receiving schedule two controlled substances

Avg: 46%

51%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 14%

$60
Average prescription price

Avg: $60

RENE BOUCHER DO

Interventional Pain Medicine

2,883

$194K

310
103 are 65+

47%
patients receiving schedule two controlled substances

Avg: 46%

62%
patients receiving schedule three controlled substances

Avg: 41%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 14%

$67
Average prescription price

Avg: $60

MARK DELOMAS M.D.

Interventional Pain Medicine

2,861

$242K

260
106 are 65+

80%
patients receiving schedule two controlled substances

Avg: 46%

34%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 14%

$85
Average prescription price

Avg: $60

CRAIG CARTIA MD

Interventional Pain Medicine

2,789

$100K

402
190 are 65+

42%
patients receiving schedule two controlled substances

Avg: 46%

57%
patients receiving schedule three controlled substances

Avg: 41%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 14%

$36
Average prescription price

Avg: $60

PETER WRIGHT M.D.

Interventional Pain Medicine

2,721

$230K

435
82 are 65+

73%
patients receiving schedule two controlled substances

Avg: 46%

28%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 14%

$84
Average prescription price

Avg: $60

ROBERT KLICKOVICH M.D.

Interventional Pain Medicine

2,398

$208K

278
150 are 65+

52%
patients receiving schedule two controlled substances

Avg: 46%

25%
patients receiving schedule three controlled substances

Avg: 41%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 14%

$87
Average prescription price

Avg: $60

ELMER DUNBAR M.D.

Interventional Pain Medicine

2,117

$86.3K

279
92 are 65+

22%
patients receiving schedule two controlled substances

Avg: 46%

65%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 14%

$41
Average prescription price

Avg: $60

BENJAMIN STOREY MD

Interventional Pain Medicine

1,899

$59.4K

340
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 46%

5%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 14%

$31
Average prescription price

Avg: $60

BALLARD WRIGHT M.D.

Interventional Pain Medicine

1,878

$104K

592
118 are 65+

70%
patients receiving schedule two controlled substances

Avg: 46%

29%
patients receiving schedule three controlled substances

Avg: 41%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 14%

$56
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank